The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Rochester
About this trial
This study evaluates the effects of a structured home exercise program in participants with pulmonary hypertension associated with interstitial lung disease. Participants will complete a defined exercise regimen over a 16-week period, and functional capacity and patient reported outcomes will be assessed at baseline and after the intervention. The study aims to determine whether a home-based exercise approach is feasible and associated with improvements in functional performance.
Eligibility criteria
Qualifiers
Follows at University of Rochester Medical Center Pulmonary Hypertension Clinic.
Adult patients (>18 years old) with right heart catheterization confirmed pulmonary hypertension interstitial lung disease on stable therapy dosing for at least 30 days.
Access to a smart phone or email to receive daily messages.
Clinically stable by the investigator.
Disqualifiers
Pregnancy.
Pulmonary Hypertension Groups 1,2,4,5.
Resting tachycardia >120 beats/m during screening.
Inability to walk.
Trial design
Treatments tested in this trial
- Home Exercise Program, Aerobic Plus Strength Training
- Home Exercise Program, Aerobic Only
Treatment groups
30 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
University of Rochester
Lead sponsor
Liquidia Technologies, Inc.
Collaborator
Source ClinicalTrials.gov